These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16969165)

  • 1. Advances in pediatric heart transplantation.
    Schowengerdt KO
    Curr Opin Pediatr; 2006 Oct; 18(5):512-7. PubMed ID: 16969165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current issues in pediatric transplantation.
    Kelly DA
    Pediatr Transplant; 2006 Sep; 10(6):712-20. PubMed ID: 16911496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy.
    Chapman JR; Valantine H; Albanell J; Arns WA; Campistol JM; Eisen H; Frigerio M; Lehmkuhl H; Marcen R; Morris R; Nashan B; Pascual J; Pohanka E; Segovia J; Zuckermann A
    Transplant Proc; 2007 Dec; 39(10):2937-50. PubMed ID: 18089298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric cardiac transplantation.
    Alkhaldi A; Chin C; Bernstein D
    Semin Pediatr Surg; 2006 Aug; 15(3):188-98. PubMed ID: 16818140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after pediatric heart transplantation: two decades of a single center experience.
    Gambino A; Cerutti A; Feltrin G; Toscano G; Tarantini G; Milanesi O; Angelini A; Gerosa G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):220-4. PubMed ID: 17590347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New advances in antirejection therapy.
    Chan M; Pearson GJ
    Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after liver transplantation in children.
    Bucuvalas JC; Alonso E
    Curr Opin Organ Transplant; 2008 Jun; 13(3):247-51. PubMed ID: 18685311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of everolimus in improving renal function in long-term heart transplantation.
    Fiocchi R; Iacovoni A; Sebastiani R; Fontana A; Gandolfi L; Gamba A
    Transplant Proc; 2007; 39(6):1967-9. PubMed ID: 17692667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric heart transplantation.
    Boucek MM; Pietra BA
    Curr Opin Cardiol; 1995 Mar; 10(2):223-8. PubMed ID: 7787289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac transplantation.
    Burdine J; Fischel RJ; Bolman RM
    Crit Care Clin; 1990 Oct; 6(4):927-45. PubMed ID: 2265387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC; Baron O; PĂ©rigaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
    J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac transplantation: a review.
    Oaks TE; Wallwork J
    Br J Biomed Sci; 1993 Sep; 50(3):200-11. PubMed ID: 8241836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac retransplantation in children.
    Mahle WT
    Pediatr Transplant; 2008 May; 12(3):274-80. PubMed ID: 18435605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The University of California at Los Angeles heart transplantation experience.
    Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
    Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late outcomes of pediatric heart transplantation are independent of pre-transplant diagnosis and prior cardiac surgical intervention.
    Dionigi B; Razzouk AJ; Hasaniya NW; Chinnock RE; Bailey LL
    J Heart Lung Transplant; 2008 Oct; 27(10):1090-5. PubMed ID: 18926399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.